Biobanking, Therapeutics & Probiotics in Microbiome Research
Posted 19th December 2018 by Jane Williams
As the world becomes increasingly aware of the important role that different bacterial ecosystems play with regards to human and animal health, there is a growing wealth of research coming out of the microbiome industry. Kristina Campbell & Marilyn White, of KC Microbiome, conducted these interviews at the Microbiome R&D and Business Collaboration Forum: USA.
Biorepositories 101 and the Cure for Cancer
Posted 24th October 2018 by Jane Williams
An Introduction to Biorepositories
Biorepositories play a huge role in cancer research and they maintain the collection of biomaterials that cover disease targets, such as oncology, dermatology, neurology, immunology, infectious diseases, autoimmune and metabolic disorders.
How Human Tissue Samples are Shaping Cancer Therapy
Posted 24th September 2018 by Jane Williams
Cancer Therapy
Thanks to advancements in human tissue sample procedures, we have been able to make major breakthroughs in cancer research. In the twenty-first century, epidemiological and clinical evidence have supported the claim that changes in metabolism can affect oncogenesis and tumour response to therapy.
It has been observed that metabolic conditions such as hyperglycemia, obesity, hyperlipidemia, and insulin resistance are directly associated with increased risk of cancer development as well as the acceleration of tumour progression. These findings indicate that statins and metformin may help decrease cancer-related deaths.
Are smaller biobanks still relevant in the era of 500,000 plus cohorts?
Posted 19th September 2018 by Jane Williams
Shona Kerr, MRC Human Genetics Unit, writes:
Large-scale national cohorts and biobanks, linked to detailed genomic, phenotypic and clinical data, are currently being created and developed through investment from a large number of governments worldwide. These data-rich resources are exemplified by the 500,000 research volunteers in the UK Biobank, a cohort established primarily to investigate the genetic and lifestyle determinants of middle and later life diseases. Now it is accessible by all health researchers worldwide and the UK Biobank is supporting an unprecedented range of novel insights into the biology of disease, from varicose veins to lifespan.